Medigen Vaccine Biologics (6547) — Tangible Net Worth Ratio
Medigen Vaccine Biologics (6547) has a Tangible Net Worth Ratio of 99.4% as of December 2025. This metric is calculated by deducting intangible assets (NT$21.14 Million) from net assets (NT$3.48 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Medigen Vaccine Biologics shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Medigen Vaccine Biologics Tangible Net Worth Ratio (2012–2025)
This chart shows how Medigen Vaccine Biologics's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 99.4%, reflecting net assets of NT$3.48 Billion with intangible assets of NT$21.14 Million TWD. Also explore Medigen Vaccine Biologics equity growth rate to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Medigen Vaccine Biologics (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Medigen Vaccine Biologics from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Medigen Vaccine Biologics.
| Year | Tangible NW Ratio | Net Assets (TWD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.4% | NT$3.48 Billion | NT$21.14 Million | NT$3.93 Billion | ▲ +0.2 pp |
| 2024 | 99.2% | NT$3.85 Billion | NT$29.38 Million | NT$4.36 Billion | ▲ +0.2 pp |
| 2023 | 99.0% | NT$3.85 Billion | NT$38.30 Million | NT$6.09 Billion | ▼ -0.1 pp |
| 2022 | 99.1% | NT$5.03 Billion | NT$45.36 Million | NT$7.35 Billion | ▲ +0.2 pp |
| 2021 | 98.9% | NT$4.68 Billion | NT$52.98 Million | NT$5.30 Billion | ▲ +0.8 pp |
| 2020 | 98.1% | NT$3.14 Billion | NT$60.01 Million | NT$3.49 Billion | ▲ +2.6 pp |
| 2019 | 95.5% | NT$1.37 Billion | NT$61.81 Million | NT$2.28 Billion | ▼ -0.2 pp |
| 2018 | 95.7% | NT$1.61 Billion | NT$69.69 Million | NT$2.18 Billion | ▲ +0.8 pp |
| 2017 | 94.9% | NT$1.52 Billion | NT$77.66 Million | NT$2.14 Billion | ▲ +0.4 pp |
| 2016 | 94.5% | NT$1.47 Billion | NT$80.53 Million | NT$1.82 Billion | ▲ +1.0 pp |
| 2015 | 93.5% | NT$1.34 Billion | NT$87.67 Million | NT$1.65 Billion | ▲ +2.3 pp |
| 2014 | 91.2% | NT$1.08 Billion | NT$95.29 Million | NT$1.21 Billion | ▲ +11.2 pp |
| 2013 | 80.0% | NT$457.94 Million | NT$91.69 Million | NT$477.40 Million | ▲ +56.8 pp |
| 2012 | 23.1% | NT$128.00 Million | NT$98.38 Million | NT$150.15 Million | — |